Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta‐analysis-Reference-Cited by-同舟云学术

Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta‐analysis

Published:2019-08-18 Issue:3 Volume:188 Page:450-459
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Puavilai Teeraya¹²,Thadanipon Kunlawat¹^ORCID,Rattanasiri Sasivimol¹,Ingsathit Atiporn¹,McEvoy Mark³,Attia John³,Thakkinstian Ammarin¹

Affiliation:

1. Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

2. Division of Hematology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

3. Centre for Clinical Epidemiology & Biostatistics Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle New Lambton NSW Australia

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16161

Reference44 articles.

1. Comparison of treatments for persistent/chronic immune thrombocytopenia: a systematic review and network meta-analysis

2. A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia

3. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura

4. AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP

5. Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-utility analysis of romiplostim for the treatment of chronic primary immune thrombocytopenia in China;Intractable & Rare Diseases Research;2024-08-31

2. Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials;Annals of Hematology;2024-06-10

3. Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia;Oncohematology;2024-04-02

4. Efficacy and Safety of Fostamatinib in Refractory Immune Thrombocytopenia: A Meta-analysis from Randomized Controlled Trials;SSRN Electronic Journal;2024

5. Guidelines for the diagnosis and management of idiopathic thrombocytopenic purpura;Russian journal of hematology and transfusiology;2023-12-28